Correlation Between Molecular Partners and Sensei Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Sensei Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Sensei Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Sensei Biotherapeutics, you can compare the effects of market volatilities on Molecular Partners and Sensei Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Sensei Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Sensei Biotherapeutics.
Diversification Opportunities for Molecular Partners and Sensei Biotherapeutics
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Molecular and Sensei is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Sensei Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sensei Biotherapeutics and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Sensei Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sensei Biotherapeutics has no effect on the direction of Molecular Partners i.e., Molecular Partners and Sensei Biotherapeutics go up and down completely randomly.
Pair Corralation between Molecular Partners and Sensei Biotherapeutics
Given the investment horizon of 90 days Molecular Partners AG is expected to generate 1.12 times more return on investment than Sensei Biotherapeutics. However, Molecular Partners is 1.12 times more volatile than Sensei Biotherapeutics. It trades about -0.18 of its potential returns per unit of risk. Sensei Biotherapeutics is currently generating about -0.23 per unit of risk. If you would invest 531.00 in Molecular Partners AG on November 29, 2024 and sell it today you would lose (44.00) from holding Molecular Partners AG or give up 8.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Molecular Partners AG vs. Sensei Biotherapeutics
Performance |
| Timeline |
| Molecular Partners |
| Sensei Biotherapeutics |
Molecular Partners and Sensei Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and Sensei Biotherapeutics
The main advantage of trading using opposite Molecular Partners and Sensei Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Sensei Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sensei Biotherapeutics will offset losses from the drop in Sensei Biotherapeutics' long position.| Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stocks Directory Find actively traded stocks across global markets |